Loading
₹1,920.00
−2.40−0.12%today
Market closed · 7 Oct, 3:30 pm
+35.84%over 1 year
Today's range
₹1,901.20₹1,932.90
52-week range
₹1,306.50₹2,100.70
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 9,116 | 924 | 10.1% | 48.77 |
| FY25 | 7,808 | 681 | 8.7% | 36.43 |
| FY24 | 6,582 | 498 | 7.6% | 27.57 |
| FY23 | 5,931 | 532 | 9.0% | 29.43 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 77.83% | 77.87% | 77.87% | 77.88% |
| FIIs | 4.88% | 3.35% | 3.59% | 3.29% |
| DIIs | 8.46% | 6.10% | 6.10% | 4.37% |
| of which mutual funds | 6.87% | 4.94% | 4.83% | 3.58% |
| Government | 0.00% | 0.00% | n/a | n/a |
| Public | 8.83% | 12.68% | 12.44% | 14.46% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Glaxosmithkline Pharmaceuticals Ltd.GLAXO | 2,628.00 | −4.61% | 44,520 |
| Emcure Pharmaceuticals Ltd.EMCURE · this stock | 1,920.00 | −0.12% | 36,424 |
| Narayana Hrudayalaya Ltd.NH | 1,721.20 | −0.15% | 35,175 |
| Wockhardt Ltd.WOCKPHARMA | 2,151.00 | −1.17% | 34,951 |
| Global Health Ltd.MEDANTA | 1,293.80 | −0.54% | 34,787 |
| Sai Life Sciences Ltd.SAILIFE | 1,558.70 | +0.04% | 33,110 |
| Dr. Lal Path Labs Ltd.LALPATHLAB | 1,938.00 | −1.33% | 32,529 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.